RRCM
ABBV icon

Rappaport Reiches Capital Management’s AbbVie ABBV Stock Holding History

Rappaport Reiches Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$1.83M Buy
8,711
+228
+3% +$44.3K 0.46% 25
2024
Q4 		$1.51M Sell
8,483
-567
-6% -$104K 0.39% 30
2024
Q3 		$1.79M Sell
9,050
-175
-2% -$32.7K 0.48% 25
2024
Q2 		$1.58M Sell
9,225
-7,090
-43% -$1.17M 0.47% 28
2024
Q1 		$2.97M Buy
16,315
+7,447
+84% +$1.28M 0.93% 20
2023
Q4 		$1.37M Buy
8,868
+170
+2% +$24.8K 0.5% 25
2023
Q3 		$1.3M Sell
8,698
-282
-3% -$41.4K 0.55% 23
2023
Q2 		$1.21M Sell
8,980
-175
-2% -$25.7K 0.51% 29
2023
Q1 		$1.46M Sell
9,155
-241
-3% -$36.8K 0.65% 22
2022
Q4 		$1.52M Sell
9,396
-233
-2% -$35.7K 0.75% 21
2022
Q3 		$1.29M Sell
9,629
-261
-3% -$37.5K 0.66% 23
2022
Q2 		$1.51M Sell
9,890
-13
-0.1% -$1.99K 0.76% 18
2022
Q1 		$1.61M Buy
9,903
+1,912
+24% +$278K 0.86% 21
2021
Q4 		$1.08M Buy
7,991
+910
+13% +$107K 0.93% 19
2021
Q3 		$764K Sell
7,081
-70
-1% -$8K 0.76% 18
2021
Q2 		$805K Buy
+7,151
New +$805K 0.85% 18

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Rappaport Reiches Capital Management's ABBV Position: Q1 2025 in Review

Rappaport Reiches Capital Management increased its AbbVie (ABBV) stake by 2.7% in Q1 2025, buying an estimated $44.3K and bringing the position to 8,711 shares worth $1.83M. The position accounts for 0.46% of the portfolio, ranked #25.

Rappaport Reiches Capital Management first reported a position in ABBV in Q2 2021 and has held it in 16 quarters since. The position peaked at $2.97M in Q1 2024. 3,819 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • Rappaport Reiches Capital Management held 8,711 shares of AbbVie worth $1.83M as of Q1 2025.
  • Rappaport Reiches Capital Management bought 228 AbbVie shares in Q1 2025, an estimated $44.3K.
  • AbbVie made up 0.46% of Rappaport Reiches Capital Management's portfolio in Q1 2025, its #25 holding.
  • Rappaport Reiches Capital Management first reported a position in AbbVie in Q2 2021 and has held it in 16 quarters since.
  • Rappaport Reiches Capital Management's AbbVie position peaked at $2.97M in Q1 2024.
  • 3,819 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on Rappaport Reiches Capital Management's 13F filing for Q1 2025, filed 22 Apr 2025.